glp 1 in europe GLP-1s the spotlight at Vitafoods conference Huge spike in the use

[DOI] [PMC free article] [PubMed] [Google Scholar] 501.Irie S., Matsumura Y., Zdravkovic M., Jacobsen L.V., Kageyama S

Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF- B and MAPK pathways via GLP-1R

One study showed the metformin-treated group showed 3.8kg of weight loss compared to sulfonylurea-treated group in 6 months

Clinical Research Overview Research examining GLP-1 medications shows that they can be effective tools for supporting weight loss and improving metabolic health

Discussing your genetic predispositions and individual biomarkers empowers your provider to tailor dosing, timing, and supportive strategies to your unique needs